Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.

banking on the strong performance of the WATCHMAN left atrial appendage closure device. In the fourth quarter of 2024, WATCHMAN sales grew 20% year over year with strong contribution from the ...

It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices ...

The Watchman FLX Left Atrial Appendage Closure (LAAC) device, in particular, has demonstrated superior bleeding risk reduction compared to oral anti-coagulation following cardiac ablation in recent ...

Pre-Market: 4:00:32 a.m. EDT Loading Chart for BSX ...

After hours: 14 March at 19:54:01 GMT-4 Loading Chart for BSX ...

He needed a left atrial appendage closure. The procedure, also called a WATCHMAN procedure – helps prevent strokes in patients with an irregular heartbeat. Joon Ahn, MD, an electrophysiologist with ...